Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.
about
The chemopreventive effects of Protandim: modulation of p53 mitochondrial translocation and apoptosis during skin carcinogenesisMetabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implicationAnti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrenceThe mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell deathExploring the electrostatic repulsion model in the role of Sirt3 in directing MnSOD acetylation status and enzymatic activityInvolvement of reactive oxygen species in 2-methoxyestradiol-induced apoptosis in human neuroblastoma cellsHexavalent chromium-induced apoptosis of granulosa cells involves selective sub-cellular translocation of Bcl-2 members, ERK1/2 and p53Novel treatment of neuroinflammation against low back pain by soluble fullerol nanoparticlesWarburg effect's manifestation in aggressive pheochromocytomas and paragangliomas: insights from a mouse cell model applied to human tumor tissue.Cancer phototherapy via selective photoinactivation of respiratory chain oxidase to trigger a fatal superoxide anion burstManganese superoxide dismutase: effect of the ala16val polymorphism on protein, activity, and mRNA levels in human breast cancer cell lines and stably transfected mouse embryonic fibroblasts.Identification of novel pathogenic copy number aberrations in multiple myeloma: the Malaysian contextThe Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanismCaveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblastsSuperoxide dismutases in chronic gastritis.Non-irradiation-derived reactive oxygen species (ROS) and cancer: therapeutic implications.Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapyMutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cellsManganese superoxide dismutase promotes anoikis resistance and tumor metastasisThe dark side of a tumor suppressor: anti-apoptotic p53.Identification of DDB2 protein as a transcriptional regulator of constitutive SOD2 gene expression in human breast cancer cellsManganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis.Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals.Manganese superoxide dismutase in cancer prevention.Targeting the mitochondrial permeability transition: cardiac ischemia-reperfusion versus carcinogenesis.2-methoxyestradiol in the pathophysiology of endometriosis: focus on angiogenesis and therapeutic potential.The effect of superoxide anion and hydrogen peroxide imbalance on prostate cancer: an integrative in vivo and in vitro analysis.Mitochondrial ROS control of cancer.Proteomic analyses of gastric cancer cells treated with vesicular stomatitis virus matrix protein.MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells.Protection by pentoxifylline of malathion-induced toxic stress and mitochondrial damage in rat brain.Energy restriction as an antitumor target.A recombinant trans-membrane protein hMnSOD-R9 inhibits the proliferation of cervical cancer cells in vitro.Prognostic significance of PUMA in pancreatic ductal adenocarcinoma.
P2860
Q21562186-C2F3BC57-6947-4886-B05E-AE9EA823711DQ26795759-0E8225CD-247F-4CF4-994C-388AD9843A00Q27010314-CA8B0AE5-2264-497C-9A6A-DD246007F3E1Q27012559-C67BB096-F639-45AE-AB80-9A38AC950141Q27014003-01277B34-917A-40CB-80EB-C7F9E2D3424AQ28394171-A8F3B0B6-9BB8-4A01-B940-10C22082CF87Q28575955-104CBB75-8CE1-4E66-9CDF-27B12B1E2E07Q30417501-320FBE0F-08F9-47FA-8318-B6F43C1CE3CCQ31079334-259A8BE4-8EF4-45E7-94D8-C7D327E1F2F3Q31134503-94E712F2-7F6C-403E-94B7-089DCDA29336Q33604153-AE4968D0-07DB-478B-937C-AD798AF48E22Q33614522-061334E9-B1F9-414E-AF1E-7388D7380DE9Q34332654-8FEA9694-C41C-4824-BB48-678171D5864CQ34616660-2C240147-A925-4449-B053-C1C4D37EA035Q35893902-D7F18576-2CE2-44E5-9A07-3F7C19809300Q36471054-EC58B56C-39B9-4D5C-891D-B91ED74090D5Q36952188-8F6537B6-C766-44B2-8378-9EEFB29E50A0Q37020835-D0FEFD9A-DA65-4E33-B85A-30E62A6FD46CQ37073610-0B967504-4A66-4B9F-B8D5-3477D3B7678AQ37115437-EDA02DAC-7A70-4495-B0DC-44A28BA6C616Q37194190-5934E3CF-B7D5-494E-AA4C-9E984B2E5A00Q37518299-C8B0A6F7-2EE3-45F1-8F8E-0A423063346CQ37529631-57E816AB-40D9-4E3A-9BDB-78719F3DB5EEQ37617676-2B214386-C893-4ED0-BC19-3405013248BBQ37862534-FA544DF8-3772-4842-9DA2-73884DB15ECCQ38033141-4F5C9F0E-0198-4B28-B2F2-54C63EA649D5Q38827836-6AC63D74-BE93-4731-97A3-DC607D7F4572Q39264659-924193C7-BD9F-4A96-9B28-A5DE5ED4DED6Q39542027-E51E8B8D-15D3-48F4-BA56-D7CDC89A1DB2Q40437328-BB04A360-63E5-4979-94C2-5D69C5C4FA96Q43145626-8411DC2F-D0EB-48B0-8B79-9780B0D57744Q51773654-1DEE4E5C-D312-4FD8-8A98-4437D6B31E6BQ53088541-781F3972-1E79-40B2-8D63-C0EA3D5EFA56Q53259577-6A7B2B91-7D2C-4686-BE1B-477FE1AB08D5
P2860
Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.
@ast
Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.
@en
type
label
Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.
@ast
Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.
@en
prefLabel
Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.
@ast
Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.
@en
P2093
P356
P1476
Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.
@en
P2093
Barbara Bedogni
Daniela Ferraro
Giovambattista Pani
Renata Colavitti
Salvatore Fusco
Silvia Borrello
Tommaso Galeotti
P304
P356
10.2174/0929867043365297
P577
2004-05-01T00:00:00Z